Cargando…

Prognostic value of postoperative decrease in serum albumin on surgically resected early-stage non-small cell lung carcinoma: A multicenter retrospective study

BACKGROUND: Preoperative nutritional status is an important host-related prognostic factor for non-small cell lung carcinoma (NSCLC); however, the significance of postoperative changes in nutritional status remains unclear. This study aimed to elucidate the significance of postoperative decreases in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kinoshita, Fumihiko, Tagawa, Tetsuzo, Yamashita, Takanori, Takenaka, Tomoyoshi, Matsubara, Taichi, Toyokawa, Gouji, Takada, Kazuki, Oba, Taro, Osoegawa, Atsushi, Yamazaki, Koji, Takenoyama, Mitsuhiro, Shimokawa, Mototsugu, Nakashima, Naoki, Mori, Masaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412276/ https://www.ncbi.nlm.nih.gov/pubmed/34473762 http://dx.doi.org/10.1371/journal.pone.0256894

Ejemplares similares

The association and prognostic impact of enhancer of zeste homologue 2 expression and epithelial–mesenchymal transition in resected lung adenocarcinoma
por: Matsubara, Taichi, et al.
Publicado: (2019)

Clinical significance of preoperative inflammatory markers in non-small cell lung cancer patients: A multicenter retrospective study
por: Takada, Kazuki, et al.
Publicado: (2020)

The significant influence of having children on the postoperative prognosis of patients with nonsmall cell lung cancer: A propensity score‐matched analysis
por: Takamori, Shinkichi, et al.
Publicado: (2018)

(18)F-FDG uptake in PET/CT is a potential predictive biomarker of response to anti-PD-1 antibody therapy in non-small cell lung cancer
por: Takada, Kazuki, et al.
Publicado: (2019)

Combination Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients with NSCLC Receiving Carboplatin-Based Chemotherapy
por: Shimokawa, Mototsugu, et al.
Publicado: (2022)

Does short-term cessation of smoking before lung resections reduce the risk of complications?
por: Takenaka, Tomoyoshi, et al.
Publicado: (2020)

Relationship between consolidation tumor ratio and tumor‐infiltrating lymphocytes in small‐sized lung adenocarcinoma
por: Ono, Yuki, et al.
Publicado: (2022)

Clinical significance of part-solid lung cancer in the eighth edition TNM staging system
por: Okamoto, Tatsuro, et al.
Publicado: (2021)

Spotlight on lorlatinib and its potential in the treatment of NSCLC: the evidence to date
por: Akamine, Takaki, et al.
Publicado: (2018)

Significance of spread through air spaces in early‐stage lung adenocarcinomas undergoing limited resection
por: Toyokawa, Gouji, et al.
Publicado: (2018)

Short progression‐free survival of ALK inhibitors sensitive to secondary mutations in ALK‐positive NSCLC patients
por: Haratake, Naoki, et al.
Publicado: (2019)

Development of artificial intelligence prognostic model for surgically resected non-small cell lung cancer
por: Kinoshita, Fumihiko, et al.
Publicado: (2023)

Atezolizumab-Induced Aseptic Meningitis in Patients with NSCLC
por: Toyozawa, Ryo, et al.
Publicado: (2020)

Lorlatinib-Induced Pulmonary Embolism in a Patient With an ALK-Positive NSCLC
por: Toyozawa, Ryo, et al.
Publicado: (2020)

Impact of the pretreatment prognostic nutritional index on the survival after first‐line immunotherapy in non‐small‐cell lung cancer patients
por: Oku, Yuka, et al.
Publicado: (2023)

Insights into brain metastasis in patients with ALK+ lung cancer: is the brain truly a sanctuary?
por: Toyokawa, Gouji, et al.
Publicado: (2015)

Association between peripheral blood markers and immune-related factors on tumor cells in patients with resected primary lung adenocarcinoma
por: Takada, Kazuki, et al.
Publicado: (2019)

Recurrence of thymic neuroendocrine carcinoma 24 years after total excision: A case report
por: TOYOKAWA, GOUJI, et al.
Publicado: (2013)

Cumulative experience of the anterior approach in robot-assisted thoracic surgery for lung cancer patients
por: Yamazaki, Koji, et al.
Publicado: (2021)

Prospective observational study of nutritional/immunologic indices as predictive biomarkers for the response to anti-PD-1 drugs in non-small cell lung cancer (ICI-PREDICT study)
por: Takamori, Shinkichi, et al.
Publicado: (2021)

IgG4-Related Lung Disease Exhibiting the Invasion into the Diaphragm: A Case Report
por: Ono, Yuki, et al.
Publicado: (2020)

The clinical impact of concomitant medication use on the outcome of postoperative recurrent non-small-cell lung cancer in patients receiving immune checkpoint inhibitors
por: Takada, Kazuki, et al.
Publicado: (2022)

The impact of immune-inflammation-nutritional parameters on the prognosis of non-small cell lung cancer patients treated with atezolizumab
por: Matsubara, Taichi, et al.
Publicado: (2020)

Pulmonary metastasis presenting as a ground glass opacity-like lesion with a thin-walled cavity: A case report
por: Haro, Akira, et al.
Publicado: (2019)

Correlation between CXCR4/CXCR7/CXCL12 chemokine axis expression and prognosis in lymph‐node‐positive lung cancer patients
por: Katsura, Masakazu, et al.
Publicado: (2017)

Prognostic impact of noninvasive areas in resected pathological stage IA lung adenocarcinoma
por: Kinoshita, Fumihiko, et al.
Publicado: (2023)

Association between sex and outcomes in patients with non-small-cell lung cancer receiving combination chemoimmunotherapy as a first-line therapy: a systematic review and meta-analysis of randomized clinical trials
por: Takada, Kazuki, et al.
Publicado: (2022)

Mutational signatures in squamous cell carcinoma of the lung
por: Osoegawa, Atsushi, et al.
Publicado: (2021)

Survival after recurrence following surgical resected non-small cell lung cancer: A multicenter, prospective cohort study
por: Takenaka, Tomoyoshi, et al.
Publicado: (2022)

A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retrospective study
por: Takada, Kazuki, et al.
Publicado: (2022)

Skeletal muscle area predicts the outcomes of non-small-cell lung cancer after trimodality therapy
por: Watanabe, Kenji, et al.
Publicado: (2023)

Metabolic characteristics of programmed cell death‐ligand 1‐expressing lung cancer on (18)F‐fluorodeoxyglucose positron emission tomography/computed tomography
por: Takada, Kazuki, et al.
Publicado: (2017)

Rapidly Destructive Coxarthrosis as a Potential Side Effect of Crizotinib in a Patient with ROS1-Positive Lung Adenocarcinoma
por: Takamori, Shinkichi, et al.
Publicado: (2020)

Association of Mps one binder kinase activator 1 (MOB1) expression with poor disease‐free survival in individuals with non‐small cell lung cancer
por: Ando, Nobuhisa, et al.
Publicado: (2020)

Paired analysis of tumor mutation burden for lung adenocarcinoma and associated idiopathic pulmonary fibrosis
por: Yoneshima, Yasuto, et al.
Publicado: (2021)

Is radical local therapy effective in postoperative recurrent EGFR ‐mutated non‐small cell lung cancer?
por: Takenaka, Tomoyoshi, et al.
Publicado: (2023)

Complete Blood Cell Count-Derived Inflammatory Biomarkers in Early-Stage Non-Small-Cell Lung Cancer
por: Shoji, Fumihiro, et al.
Publicado: (2020)

Impact of Preoperative Immunonutritional Support in Patients Undergoing Elective Thoracic Surgery
por: Shoji, Fumihiro, et al.
Publicado: (2021)

Assessment of the albumin-bilirubin grade as a prognostic factor in patients with non-small-cell lung cancer receiving anti-PD-1-based therapy
por: Takada, K., et al.
Publicado: (2021)

Re: COVID-19 in patients with neuroendocrine neoplasms: Preliminary results of a worldwide survey (The INTENSIVE study)
por: Takada, Kazuki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kgostmffvtl4e3iuecapmm2sn8